4th Quarter - Report
CAREDX, INC. for CAREDX, INC.
Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
-Medicare coverage of molecular testing for solid organ allograft rejection -Medicare payment of clinical laboratory tests; implementation of Sec 216 of the Protecting Access to Medicare Act of 2014 (PL 113-93) and RESULTS Act (HR5269) -Prior authorization of molecular tests
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY LINTHICUM | LD, Rep. Bob Franks |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.